Literature DB >> 25360340

Assessing preoperative frailty utilizing validated geriatric mortality calculators and their association with postoperative hip fracture mortality risk.

Jennifer G Dwyer1, Jason F Reynoso1, Georgia A Seevers2, Kendra K Schmid3, Padmashri Muralidhar1, Beau Konigsberg4, Thomas G Lynch2, Jason M Johanning2.   

Abstract

INTRODUCTION: End-of-life surgical care is a major concern with a significant number of operations performed within the last year of life; surgery for hip fractures is a prime example. Unfortunately, no simple objective tool exists to assess life expectancy in the postoperative period. The goal of our study was to analyze 2 simple geriatric life expectancy calculators to compare with the current Veterans Affairs Surgical Quality Improvement Program (VASQIP) postoperative 30-day mortality calculator.
METHODS: This retrospective study assessed the utility of 3 validated calculators in 47 hip fracture repairs from July 2009 to May 2011. The tools included: 30-day VASQIP mortality calculator, 6-month Minimum Data Set Mortality Risk Index-Revised (MMRI-R), and Four-Year Mortality Index. The VASQIP calculator requires chart review, Current Procedural Terminology (CPT) codes, and laboratory analysis, whereas the mortality risk indices require simple patient questioning if prospective or simple chart review if retrospective. Scoring was performed and mortality risk was compared between survivors and nonsurvivors.
RESULTS: A total of 47 hip fractures were repaired during the study period with 37 survivors and 10 nonsurvivors. In all, 7 died within 30 days, 2 died within 6 months, and 1 died greater than 6 months after surgery. The mean age (standard deviation [SD]) of all patients undergoing hip fracture repair was 73.6 (13.3) years. The VASQIP calculator mean (SD) 30-day mortality risk was 10.4% (5.4) for nonsurvivors compared to survivors 4.3% (5.5), P < .003; the MMRI-R mean (SD) mortality risk was 35.8% (15.4) for nonsurvivors compared to survivors 14.7% (9.5), P < .001; the Four-Year Mortality Index mean (SD) mortality risk was 60.9% (16.9) for nonsurvivors compared to survivors 48.9% (24.4), P < .09.
CONCLUSION: Overall, the VASQIP 30-day and MMRI-R 6-month mortality calculators showed significant differences in mortality risk between survivors versus nonsurvivors in a population with hip fracture. In contrast, the Four-Year Mortality calculator may not sufficiently discriminate operative risk. The easily obtained MMRI-R has the potential to provide information on short-term postoperative mortality risk.

Entities:  

Keywords:  frailty; hip fracture; mortality; paper; postoperative; risk

Year:  2014        PMID: 25360340      PMCID: PMC4212426          DOI: 10.1177/2151458514537272

Source DB:  PubMed          Journal:  Geriatr Orthop Surg Rehabil        ISSN: 2151-4585


  12 in total

1.  Nonoperative treatment of hip fractures.

Authors:  Rina Jain; Antoni Basinski; Hans J Kreder
Journal:  Int Orthop       Date:  2002-11-12       Impact factor: 3.075

Review 2.  Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care.

Authors:  Linda P Fried; Luigi Ferrucci; Jonathan Darer; Jeff D Williamson; Gerard Anderson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-03       Impact factor: 6.053

Review 3.  Frailty in the older surgical patient: a review.

Authors:  Judith S L Partridge; Danielle Harari; Jugdeep K Dhesi
Journal:  Age Ageing       Date:  2012-03       Impact factor: 10.668

4.  Early palliative care for patients with metastatic non-small-cell lung cancer.

Authors:  Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

5.  Predictors of mortality in older hip fracture inpatients admitted to an orthogeriatric unit in oslo, norway.

Authors:  Kristin Holvik; Anette Hylen Ranhoff; Mette Irene Martinsen; Ludvig Fjeld Solheim
Journal:  J Aging Health       Date:  2010-09-29

6.  Frailty as a predictor of surgical outcomes in older patients.

Authors:  Martin A Makary; Dorry L Segev; Peter J Pronovost; Dora Syin; Karen Bandeen-Roche; Purvi Patel; Ryan Takenaga; Lara Devgan; Christine G Holzmueller; Jing Tian; Linda P Fried
Journal:  J Am Coll Surg       Date:  2010-04-28       Impact factor: 6.113

7.  Frailty predicts increased hospital and six-month healthcare cost following colorectal surgery in older adults.

Authors:  Thomas N Robinson; Daniel S Wu; Gregory V Stiegmann; Marc Moss
Journal:  Am J Surg       Date:  2011-09-03       Impact factor: 2.565

8.  Results of non-operative treatment following hip fracture compared to surgical intervention.

Authors:  M Hossain; V Neelapala; J G Andrew
Journal:  Injury       Date:  2009-02-23       Impact factor: 2.586

9.  The MDS Mortality Risk Index: The evolution of a method for predicting 6-month mortality in nursing home residents.

Authors:  Davina Porock; Debra Parker-Oliver; Gregory F Petroski; Marilyn Rantz
Journal:  BMC Res Notes       Date:  2010-07-16

10.  Development and validation of a prognostic index for 4-year mortality in older adults.

Authors:  Sei J Lee; Karla Lindquist; Mark R Segal; Kenneth E Covinsky
Journal:  JAMA       Date:  2006-02-15       Impact factor: 56.272

View more
  9 in total

1.  Percutaneous cholecystostomy: prognostic factors and comparison to cholecystectomy.

Authors:  Tyler J Loftus; Elisha M Collins; Camille G Dessaigne; Amber N Himmler; Alicia M Mohr; Ryan M Thomas; Charles E Hobson; George A Sarosi; William J Zingarelli
Journal:  Surg Endosc       Date:  2017-04-13       Impact factor: 4.584

Review 2.  Post-discharge complications in postoperative patients with hip fracture.

Authors:  Umi Istianah; Intansari Nurjannah; Rahadyan Magetsari
Journal:  J Clin Orthop Trauma       Date:  2020-10-24

3.  Development and Initial Validation of the Risk Analysis Index for Measuring Frailty in Surgical Populations.

Authors:  Daniel E Hall; Shipra Arya; Kendra K Schmid; Casey Blaser; Mark A Carlson; Travis L Bailey; Georgia Purviance; Tammy Bockman; Thomas G Lynch; Jason Johanning
Journal:  JAMA Surg       Date:  2017-02-01       Impact factor: 14.766

4.  Association of a Frailty Screening Initiative With Postoperative Survival at 30, 180, and 365 Days.

Authors:  Daniel E Hall; Shipra Arya; Kendra K Schmid; Mark A Carlson; Pierre Lavedan; Travis L Bailey; Georgia Purviance; Tammy Bockman; Thomas G Lynch; Jason M Johanning
Journal:  JAMA Surg       Date:  2017-03-01       Impact factor: 14.766

5.  How Does Frailty Factor Into Mortality Risk Assessment of a Middle-Aged and Geriatric Trauma Population?

Authors:  Sanjit R Konda; Ariana Lott; Hesham Saleh; Sebastian Schubl; Jeffrey Chan; Kenneth A Egol
Journal:  Geriatr Orthop Surg Rehabil       Date:  2017-10-25

6.  Frailty and Short-Term Outcomes in Patients With Hip Fracture.

Authors:  Elizabeth A Kistler; Joseph A Nicholas; Stephen L Kates; Susan M Friedman
Journal:  Geriatr Orthop Surg Rehabil       Date:  2015-09

7.  Is Scheduled Intravenous Acetaminophen Effective in the Pain Management Protocol of Geriatric Hip Fractures?

Authors:  Alexander J Bollinger; Paul D Butler; Matthew S Nies; Debra L Sietsema; Clifford B Jones; Terrence J Endres
Journal:  Geriatr Orthop Surg Rehabil       Date:  2015-09

8.  Interventions to prevent or reduce the level of frailty in community-dwelling older adults: a protocol for a scoping review of the literature and international policies.

Authors:  Martine T E Puts; Samar Toubasi; Esther Atkinson; Ana Patricia Ayala; Melissa Andrew; Maureen C Ashe; Howard Bergman; Jenny Ploeg; Katherine S McGilton
Journal:  BMJ Open       Date:  2016-03-02       Impact factor: 2.692

Review 9.  What do we know about frailty in the acute care setting? A scoping review.

Authors:  Olga Theou; Emma Squires; Kayla Mallery; Jacques S Lee; Sherri Fay; Judah Goldstein; Joshua J Armstrong; Kenneth Rockwood
Journal:  BMC Geriatr       Date:  2018-06-11       Impact factor: 3.921

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.